We could not find any results for:
Make sure your spelling is correct or try broadening your search.
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Top Brokers
Investor discussions surrounding Animalcare Group Plc (ANCR) have centered on the recent acquisition of Randlab, with a notable focus on the strategic implications for future product development. An investor, p1nkfish, highlighted that the founder of Randlab desires a partnership with ANCR, suggesting a positive outlook for the company's trajectory. Simon Gordon referred to comments from Panmure, who noted that the deal was structured to ensure that Randlab would benefit from the founder's expertise, particularly in new product development. This indicates an ongoing commitment to innovation, which could bode well for ANCR's market position.
Overall, investor sentiment appears cautiously optimistic, as discussions reflect a sense of confidence in ANCR's potential. There is a recognition of the equine market's affluent nature, as pointed out by p1nkfish, which emphasizes the company's promising future, provided that investors exercise patience. References to insights shared by Stephen English further bolster this sentiment, indicating institutional interest and engagement, potentially leading to favorable developments for ANCR. Quotes from the discussion reinforce this positive outlook, with participants expressing hope and interest in the company's evolving role in the sector.
Show more
Animalcare Group PLC has reported a positive trading outlook for the fiscal year ending December 31, 2024, highlighting revenues of approximately £74.2 million, representing a 4.9% increase compared to £70.7 million in 2023. This performance aligns with market expectations, with particularly strong sales observed in their core product segments. The growth was driven primarily by strong demand for the Plaqtiv+ oral health range and the Daxocox brand. Additionally, when factoring in constant exchange rates, the revenue growth rises to approximately 7.2%.
In a separate update, the company announced the exercise of options under its Long Term Incentive Plan, resulting in the issuance of 8,497 new ordinary shares. The shares are expected to begin trading on the London Stock Exchange effective January 24, 2025. This reflects ongoing engagement with its compensation strategy and aims to align management incentives with shareholder interests. Overall, these developments showcase Animalcare's strong market positioning and proactive management strategies as the company continues to thrive in the competitive animal health sector.
Show more
that video now on ggp share board , a good example for other shares |
The growth in pet ownership over lockdown and owner’s desires to keep their pets fit and healthy has been great news for the pet care sector. However, who are going to be the long-term winners from the current pet boom? |
The website identibase is in complete disarray at present, shambolic. Vets, animal charities and private individuals unable to register chips they have paid for.Fraudulent incompetence over the last few weeks |
The latest interim results suggest that the efforts of newish CEO Jenny Winter appearing to be bearing fruit, despite the short term disruptions. |
The full statement from the auditor's report - Hedging opinion (imo) |
Hello Everyone,Not sure if you have seen this, re Animalcare."Animalca |
Tipped by Chris Boxall of FAM today. |
Perking up on some chunky volume |
i remember this one - i was looking at it pre-merger and never really understood why the management went for it. Guess I will look in after the results at the end of the month but the text from the statements doesn't fit with the figures. Having worked in a bank turnaround story for 10 years - I've seen many new CEOs come in and kitchen sink the first set of results and we'll have to see if Jenny Winter does the same. |
that is one nasty looking chart |
time this one started to lose the "dog status" if you know what i mean - welcoming all new posters for comments - good luck all |
i have set up a new thread that may (?) help the price (?) if nothing else ; this one is 11 years old - welcome to see posters over there - see if this dog can start to turn |
New CEO in Jenny Winter recently appointed has an opportunity to finally put this business back on track. |
2019 AGM |
Hmm what is going on here? I was looking at this stock in 2017 as it was held by some AIM VCTs I was look into. Then this transaction went ahead and put my off as it felt like empire building. What do people think? |
Not bad today |
I think there is accumulation going on here. Outstanding share are very low. Someone is looking to get more. Does anybody have level 2 to see if there is a big order ? |
Type | Ordinary Share |
Share ISIN | GB0032350695 |
Sector | Veterinary Service-livestock |
Bid Price | 232.00 |
Offer Price | 240.00 |
Open | 236.00 |
Shares Traded | 7,176 |
Last Trade | 08:00:00 |
Low - High | 236.00 - 236.00 |
Turnover | 74.35M |
Profit | 1.2M |
EPS - Basic | 0.0174 |
PE Ratio | 135.63 |
Market Cap | 162.8M |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads